Detalles de la búsqueda
1.
Fasting-mimicking diet: a metabolic approach for the treatment of breast cancer.
Curr Opin Oncol
; 35(6): 491-499, 2023 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37621169
2.
Everolimus versus alpelisib in advanced hormone receptor-positive HER2-negative breast cancer: targeting different nodes of the PI3K/AKT/mTORC1 pathway with different clinical implications.
Breast Cancer Res
; 22(1): 33, 2020 04 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32252811
3.
Cyclic Fasting-Mimicking Diet Plus Bortezomib and Rituximab Is an Effective Treatment for Chronic Lymphocytic Leukemia.
Cancer Res
; 84(7): 1133-1148, 2024 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38241703
4.
Breast cancers arising in subjects with germline BRCA1 or BRCA2 mutations: Different biological and clinical entities with potentially diverse therapeutic opportunities.
Crit Rev Oncol Hematol
; 190: 104109, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37643668
5.
Efficacy and Safety of First-line Carboplatin-paclitaxel and Carboplatin-gemcitabine in Patients With Advanced Triple-negative Breast Cancer: A Monocentric, Retrospective Comparison.
Clin Breast Cancer
; 23(3): e151-e162, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36599769
6.
The pan-immune-inflammation value is associated with clinical outcomes in patients with advanced TNBC treated with first-line, platinum-based chemotherapy: an institutional retrospective analysis.
Ther Adv Med Oncol
; 15: 17588359231165978, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37063779
7.
Guideline-Based Follow-Up Outcomes in Patients With Gastrointestinal Stromal Tumor With Low Risk of Recurrence: A Report From the Italian Sarcoma Group.
JAMA Netw Open
; 6(11): e2341522, 2023 Nov 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37930700
8.
Prognostic significance of HER2-low status in HR-positive/HER2-negative advanced breast cancer treated with CDK4/6 inhibitors.
NPJ Breast Cancer
; 9(1): 27, 2023 Apr 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-37069173
9.
Peripheral blood lymphocytes predict clinical outcomes in hormone receptor-positive HER2-negative advanced breast cancer patients treated with CDK4/6 inhibitors.
Ther Adv Med Oncol
; 15: 17588359231204857, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-38130467
10.
Prognostic impact of body mass index (BMI) in HER2+ breast cancer treated with anti-HER2 therapies: from preclinical rationale to clinical implications.
Ther Adv Med Oncol
; 14: 17588359221079123, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35281350
11.
Exceptional tumour responses to fasting-mimicking diet combined with standard anticancer therapies: A sub-analysis of the NCT03340935 trial.
Eur J Cancer
; 172: 300-310, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35810555
12.
Case Report: Prolonged clinical benefit with sequential trastuzumab-containing treatments in a patient with advanced extramammary Paget disease of the groin.
Front Oncol
; 12: 925551, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36059635
13.
Predictive Role of CD36 Expression in HER2-Positive Breast Cancer Patients Receiving Neoadjuvant Trastuzumab.
J Natl Cancer Inst
; 114(12): 1720-1727, 2022 12 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35789270
14.
Fasting-Mimicking Diet Is Safe and Reshapes Metabolism and Antitumor Immunity in Patients with Cancer.
Cancer Discov
; 12(1): 90-107, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34789537
15.
HER2 Signaling and Breast Cancer Stem Cells: The Bridge behind HER2-Positive Breast Cancer Aggressiveness and Therapy Refractoriness.
Cancers (Basel)
; 13(19)2021 Sep 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-34638263
16.
Prolonged benefit from palbociclib plus letrozole in heavily pretreated advanced male breast cancer: case report.
Tumori
; 107(6): NP15-NP19, 2021 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-33297845
17.
Risk assessment of thromboembolic events in hospitalized cancer patients.
Sci Rep
; 11(1): 18200, 2021 09 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-34521927
18.
Impact of Pathological Stratification on the Clinical Outcomes of Advanced Well-Differentiated/Dedifferentiated Liposarcoma Treated with Trabectedin.
Cancers (Basel)
; 13(6)2021 Mar 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-33810165
19.
Hormone receptor status influences the impact of body mass index and hyperglycemia on the risk of tumor relapse in early-stage HER2-positive breast cancer patients.
Ther Adv Med Oncol
; 13: 17588359211006960, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33948122
20.
Targeting lipid metabolism is an emerging strategy to enhance the efficacy of anti-HER2 therapies in HER2-positive breast cancer.
Cancer Lett
; 511: 77-87, 2021 07 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-33961924